Table 2.
The incidence of AKI in COVID-19 patients.
| Study | Number of included studies | Population | Incidence of AKI (95% CI) | I2 (p-value) | References |
|---|---|---|---|---|---|
| Zhou, S., 2020 | 58 | All COVID-19 patients | 9% (4.2–15.2%) | NA | (26) |
| Hansrivijit, P., 2020 | 26 | All COVID-19 patients | 8.4% (6.0–11.7%) | 88.9% | (25) |
| Critically ill COVID-19 patients | 19.9% (11.8–31.5%) | 48.4% | |||
| Hospitalized COVID-19 patients | 7.3% (5.0–10.4%) | 89.5% | |||
| Fu, E. L., 2020 | 142 | COVID-19 patients in Asia | 5.5% (4.1–7.4%) | 94% | (30) |
| COVID-19 patients in the USA and Europe | 28.6% (19.8–39.5%) | 97% | |||
| Chan, K. W., 2021 | 74 | All COVID-19 patients | 20.4% (12.07–28.74%) | 99.72% (<0.001) | (41) |
| COVID-19 patients with kidney transplant history | 35.99% (26.20–45.79) | NA | |||
| Pediatric COVID-19 patients | 16.11% (5.14–27.08) | NA | |||
| Chung, E. Y., 2021 | 348 | Patients with COVID-19 and CKD | 7.3% (6–8.7%) | NA | (17) |
| Chang, R., 2021 | 28 | COVID-19 patients admitted to ICU | 32% (13–58%) | 96.49 % (<0.01) | (36) |